Editor's Note This study by researchers at UC San Francisco finds that step counts—a measure of physical activity—were markedly lower early in the COVID-19 pandemic compared to prepandemic, and they remain lower in the 2 years following the onset of the pandemic. The researchers used data collected from the Azumio…

Read More

Editor's Note The Food and Drug Administration (FDA) on August 29 identified the recall by Hamilton Medical AG of its Hamilton-C6 Intensive Care Ventilator as Class I, the most serious. The recall was initiated because of potential water ingress between the indicator board and the ventilator’s main board that may…

Read More

Editor's Note This study from Saudi Arabia finds that nurses working in the intensive care unit (ICU) had a significantly higher risk of COVID-19 infection. A total of 1,594 healthcare workers (HCWs) with COVID-19 infections were analyzed—103 working in the ICU and 1,491 working in non-ICU locations. The ICU had…

Read More

Editor's Note The Joint Commission on August  31 announced a new patient safety campaign to help patients understand telehealth visits, titled: “Speak Up At Your Telehealth Visit.” Educational resources for the Speak Up program include: an infographic poster/flyer an animated video a distribution guide on how to provide the materials…

Read More

Editor's Note This phase 3, double-blind, randomized, placebo-controlled study led by researchers at the University of Minnesota, Minneapolis, finds that none of three medications evaluated—metformin, ivermectin, or fluvoxamine—prevented the occurrence of a primary event—hypoxemia, an emergency department (ED) visit, hospitalization, or death—associated with COVID-19. Of 1,323 patients analyzed, a primary…

Read More

Editor's Note The Food and Drug Administration on August 29 identified the recall by Intera Oncology of its Intera 3000 Hepatic Artery Infusion Pump as Class I, the most serious. The company is recalling the pumps after receiving reports from clinicians that the pumps were delivering medication faster than expected.…

Read More

Editor's Note This study led by researchers at the University of North Carolina School of Medicine, Chapel Hill, finds that nearly 72% of healthcare providers in US safety net practices experienced either mild or intense levels of moral distress during the first year of COVID-19 because of issues with patient…

Read More

Editor's Note ECRI, on August 29, announced its new guidance on “Supporting Resilience in Healthcare Workers” that was published on August 15 for its members. With a new focus on protecting healthcare workers against burnout and other behavioral health issues, new strategies for protecting and maintaining resilience have emerged, ECRI…

Read More

Editor's Note This study (CRISTAL randomized trial) from Australia finds that aspirin compared with enoxaparin resulted in significantly higher rates of venous thromboembolism (VTE) after total hip or knee arthroplasty. This cluster-randomized, crossover trial included 9,711 patients in 31 hospitals in Australia—5,675 in the aspirin group and 4,036 in the…

Read More

Editor's Note The Food and Drug Administration on August 25 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) system batteries as Class I, the most serious. Medtronic is recalling the batteries because they may experience electrical faults that cause them to unexpectedly fail. A similar recall…

Read More